Snowden Capital Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $288K | Buy |
2,780
+216
| +8% | +$24.5K | 0.01% | 1053 |
|
|
2025
Q4 | $259K | Sell |
2,564
-598
| -19% | -$64.9K | 0.01% | 1104 |
|
|
2025
Q3 | $390K | Buy |
3,162
+615
| +24% | +$76.3K | 0.01% | 905 |
|
|
2025
Q2 | $306K | Sell |
2,547
-631
| -20% | -$84.2K | 0.01% | 995 |
|
|
2025
Q1 | $468K | Buy |
3,178
+593
| +23% | +$90.6K | 0.02% | 771 |
|
|
2024
Q4 | $420K | Sell |
2,585
-195
| -7% | -$31.9K | 0.01% | 842 |
|
|
2024
Q3 | $453K | Sell |
2,780
-8
| -0.3% | -$1.19K | 0.01% | 817 |
|
|
2024
Q2 | $380K | Buy |
2,788
+103
| +4% | +$14.3K | 0.01% | 875 |
|
|
2024
Q1 | $411K | Buy |
2,685
+314
| +13% | +$46.9K | 0.01% | 844 |
|
|
2023
Q4 | $338K | Buy |
2,371
+803
| +51% | +$107K | 0.01% | 867 |
|
|
2023
Q3 | $206K | Sell |
1,568
-1,137
| -42% | -$173K | 0.01% | 1010 |
|
|
2023
Q2 | $430K | Sell |
2,705
-486
| -15% | -$78.4K | 0.02% | 803 |
|
|
2023
Q1 | $505K | Sell |
3,191
-501
| -14% | -$75.1K | 0.02% | 727 |
|
|
2022
Q4 | $518K | Buy |
3,692
+167
| +5% | +$23.7K | 0.02% | 696 |
|
|
2022
Q3 | $452K | Buy |
3,525
+83
| +2% | +$12K | 0.02% | 687 |
|
|
2022
Q2 | $485K | Sell |
3,442
-640
| -16% | -$91.4K | 0.02% | 646 |
|
|
2022
Q1 | $567K | Sell |
4,082
-2,175
| -35% | -$333K | 0.02% | 587 |
|
|
2021
Q4 | $1.09M | Sell |
6,257
-1,326
| -17% | -$221K | 0.06% | 317 |
|
|
2021
Q3 | $1.26M | Buy |
7,583
+152
| +2% | +$26.2K | 0.06% | 328 |
|
|
2021
Q2 | $1.34M | Buy |
7,431
+3,639
| +96% | +$664K | 0.07% | 325 |
|
|
2021
Q1 | $731K | Buy |
3,792
+274
| +8% | +$52.7K | 0.04% | 404 |
|
|
2020
Q4 | $710K | Sell |
3,518
-468
| -12% | -$96.8K | 0.05% | 366 |
|
|
2020
Q3 | $838K | Sell |
3,986
-125
| -3% | -$27.8K | 0.07% | 288 |
|
|
2020
Q2 | $902K | Buy |
4,111
+646
| +19% | +$129K | 0.08% | 276 |
|
|
2020
Q1 | $600K | Buy |
3,465
+1,604
| +86% | +$265K | 0.07% | 312 |
|
|
2019
Q4 | $286K | Hold |
1,861
| – | – | 0.03% | 495 |
|
|
2019
Q3 | $283K | Buy |
1,861
+60
| +3% | +$9.48K | 0.03% | 436 |
|
|
2019
Q2 | $276K | Buy |
+1,801
| New | +$275K | 0.03% | 424 |
|
|
2019
Q1 | – | Sell |
-1,581
| Closed | -$244K | – | 494 |
|
|
2018
Q4 | $244K | Buy |
1,581
+12
| +0.8% | +$1.87K | 0.03% | 416 |
|
|
2018
Q3 | $236K | Buy |
+1,569
| New | +$223K | 0.03% | 439 |
|
Other funds holding CLX
VCM
VPM
DAM
Snowden Capital Advisors's CLX Position: Q1 2026 in Review
Snowden Capital Advisors increased its Clorox (CLX) stake by 8.4% in Q1 2026, buying an estimated $24.5K and bringing the position to 2,780 shares worth $288K. The position accounts for 0.01% of the portfolio, ranked #1053.
Snowden Capital Advisors first reported a position in CLX in Q3 2018 and has held it in 30 quarters since. The position peaked at $1.34M in Q2 2021. 1,081 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Snowden Capital Advisors held 2,780 shares of Clorox worth $288K as of Q1 2026.
- Snowden Capital Advisors bought 216 Clorox shares in Q1 2026, an estimated $24.5K.
- Clorox made up 0.01% of Snowden Capital Advisors's portfolio in Q1 2026, its #1053 holding.
- Snowden Capital Advisors first reported a position in Clorox in Q3 2018 and has held it in 30 quarters since.
- Snowden Capital Advisors's Clorox position peaked at $1.34M in Q2 2021.
- 1,081 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.